I am a Vectibix (panitumumab) patient in Great Britain or Northern Ireland or a member of the UK public

You are now leaving vectibix.co.uk
Amgen does not endorse or accept liability for sites controlled by third parties

For medical information or requests please contact Amgen at gbinfoline@amgen.com / +44 (0) 1223 436441

For further information please see the Vectibix^® (panitumumab) Summary of Product Characteristics and Patient Information Leaflet:

Summary of Product Characteristics Great Britain

Summary of Product Characteristics Northern Ireland

Patient Information Leaflet Great Britain

Patient Information Leaflet Northern Ireland

REPORTING OF SIDE EFFECTS

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple Store.

By reporting side effects you can help provide more information on the safety of this medicine. Side effects should also be reported to Amgen Limited on +44 (0) 1223 436441.

Information for members of the UK public

REPORTING OF SIDE EFFECTS